Suppr超能文献

循环血清 25-羟维生素 D 水平与骨密度:孟德尔随机研究。

Circulating Serum 25-Hydroxyvitamin D Levels and Bone Mineral Density: Mendelian Randomization Study.

机构信息

Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

出版信息

J Bone Miner Res. 2018 May;33(5):840-844. doi: 10.1002/jbmr.3389. Epub 2018 Feb 9.

Abstract

There is considerable discussion of the importance for increased serum 25-hydroxyvitamin D (S-25OHD) concentration associated with adequacy for bone health. Accordingly, whether long-term high S-25OHD concentration in general positively affects bone mineral density (BMD) is uncertain. We used a Mendelian randomization design to determine the association between genetically increased S-25OHD concentrations and BMD. Five single-nucleotide polymorphisms (SNPs) in or near genes encoding enzymes and carrier proteins involved in vitamin D synthesis or metabolism were used as instrumental variables to genetically predict 1 standard deviation increase in S-25OHD concentration. Summary statistics data for the associations of the S-25OHD-associated SNPs with dual-energy X-ray absorptiometry (DXA)-derived femoral neck and lumbar spine BMD were obtained from the Genetic Factors for Osteoporosis (GEFOS) Consortium (32,965 individuals) and ultrasound-derived heel estimated BMD from the UK Biobank (142,487 individuals). None of the SNPs were associated with BMD at Bonferroni-corrected significance level, but there was a suggestive association between rs6013897 near CYP24A1 and femoral neck BMD (p = 0.01). In Mendelian randomization analysis, genetically predicted 1 standard deviation increment of S-25OHD was not associated with higher femoral neck BMD (SD change in BMD 0.02; 95% confidence interval [CI] -0.03 to 0.07; p = 0.37), lumbar spine BMD (SD change in BMD 0.02; 95% CI -0.04 to 0.08; p = 0.49), or estimated BMD (g/cm change in BMD -0.03; 95% CI -0.05 to -0.01; p = 0.02). This study does not support a causal association between long-term elevated S-25OHD concentrations and higher BMD in generally healthy populations. These results suggest that more emphasis should be placed on the development of evidence-based cut-off points for vitamin D inadequacy rather than a general recommendation to increase S-25OHD. © 2018 American Society for Bone and Mineral Research.

摘要

人们普遍认为,血清 25-羟维生素 D(S-25OHD)浓度升高与骨骼健康密切相关。因此,长期高浓度 S-25OHD 是否会对骨密度(BMD)产生积极影响尚不确定。本研究采用孟德尔随机化设计来确定 S-25OHD 浓度升高与 BMD 之间的关联。使用 5 个单核苷酸多态性(SNP)作为工具变量,这些 SNP 位于编码维生素 D 合成或代谢相关酶和载体蛋白的基因内或附近,可用于预测 S-25OHD 浓度增加 1 个标准差。从骨质疏松症遗传因素(GEFOS)联盟(32965 人)获得与 S-25OHD 相关 SNP 与双能 X 射线吸收法(DXA)衍生的股骨颈和腰椎 BMD 关联的汇总统计数据,从英国生物银行(142487 人)获得超声衍生的足跟估计 BMD。在 Bonferroni 校正的显著性水平下,没有 SNP 与 BMD 相关,但在 CYP24A1 附近的 rs6013897 与股骨颈 BMD 之间存在提示性关联(p=0.01)。在孟德尔随机化分析中,预测的 S-25OHD 浓度增加 1 个标准差与股骨颈 BMD 升高无关(BMD 的 SD 变化为 0.02;95%置信区间[CI]为-0.03 至 0.07;p=0.37),腰椎 BMD(SD 变化为 0.02;95%CI 为-0.04 至 0.08;p=0.49)或估计的 BMD(BMD 的 g/cm 变化为-0.03;95%CI 为-0.05 至-0.01;p=0.02)。本研究不支持长期升高的 S-25OHD 浓度与一般健康人群中更高的 BMD 之间存在因果关系。这些结果表明,应更加重视制定基于证据的维生素 D 不足的切点,而不是一般建议增加 S-25OHD。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验